Inhaled clofazimine adminsitration increases antimycobacterial effect compared to oral administration in a hollow-fibre system
AIM: To compare the antimycobacterial effect of inhaled versus oral clofazimine administration with an azithromycin-ethambutol backbone. BACKGROUND: Mycobacterium avium complex causes non-tuberculous pulmonary disease. Clofazimine can replace rifampicine in combination with an azithromycin-ethambuto...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Elsevier
2024-12-01
|
| Collection: | Journal of Global Antimicrobial Resistance |
| Sujets: | |
| Accès en ligne: | http://www.sciencedirect.com/science/article/pii/S221371652400362X |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|
